Alcon Inc (ALC)
88.83
-0.23
(-0.26%)
USD |
NYSE |
May 17, 16:00
88.83
0.00 (0.00%)
After-Hours: 20:00
Alcon Total Liabilities (Quarterly): 8.738B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.738B |
| December 31, 2023 | 8.99B |
| December 31, 2022 | 9.488B |
| September 30, 2022 | 8.149B |
| June 30, 2022 | 8.186B |
| March 31, 2022 | 8.304B |
| December 31, 2021 | 8.743B |
| September 30, 2021 | 8.709B |
| Date | Value |
|---|---|
| June 30, 2021 | 8.686B |
| March 31, 2021 | 8.455B |
| December 31, 2020 | 8.778B |
| September 30, 2020 | 8.758B |
| June 30, 2020 | 8.708B |
| March 31, 2020 | 8.028B |
| December 31, 2019 | 8.352B |
| December 31, 2018 | 4.423B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.028B
Minimum
Mar 2020
9.488B
Maximum
Dec 2022
8.605B
Average
8.708B
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Novartis AG | 54.58B |
| AC Immune SA | 25.05M |
| CRISPR Therapeutics AG | 355.08M |
| Addex Therapeutics Ltd | 4.163M |
| NLS Pharmaceutics Ltd | 6.557M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.56B |
| Shareholders Equity (Quarterly) | 20.83B |
| Debt to Equity Ratio | 0.2252 |
| Current Ratio | 2.512 |
| Net Debt Paydown Yield | -0.03% |